BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

642 related articles for article (PubMed ID: 16123828)

  • 1. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
    Chng WJ; Sum C; Kuperan P
    Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on usefulness of different APTT test kit in variable coagulopathy].
    Naito S; Ieko M; Yoshida M; Tarumi T; Nakabayashi T; Nishio H; Atsumi T
    Rinsho Byori; 2008 Mar; 56(3):195-202. PubMed ID: 18411803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged aPTT after kidney transplantation due to transient lupus anticoagulants.
    Nybo M; Dieperink H; Kristensen SR
    Nephrol Dial Transplant; 2006 Apr; 21(4):1060-5. PubMed ID: 16384821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal.
    Bowyer A; Smith J; Woolley AM; Kitchen S; Hampton KK; Maclean RM; VAN Veen JJ; Makris M
    Int J Lab Hematol; 2011 Apr; 33(2):212-8. PubMed ID: 20880301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of prolonged APTT and lupus anticoagulant in autoimmune thyroid disease].
    Tani Y; Morita M; Noguchi S
    Rinsho Byori; 1997 Sep; 45(9):899-902. PubMed ID: 9311265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unsuspected prolonged activated partial thromboplastin time in emergency surgery. Diagnostic and therapeutic guide].
    Barrio J; Peris V; Asensio I; Molina I; López F; García V
    Rev Esp Anestesiol Reanim; 2002 Oct; 49(8):424-7. PubMed ID: 12455323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.
    Horellou MH; Aurousseau MH; Boffa MC; Conrad J; Wiesel ML; Samama M
    J Med; 1987; 18(3-4):199-217. PubMed ID: 3480933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lupus anticoagulant neutralization procedure using the patient's own platelets.
    Carroll P; Ray M; Just S; Hawson G
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):523-7. PubMed ID: 7841308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated partial thromboplastin time reagent sensitivity to the presence of the lupus anticoagulant.
    Adcock DM; Marlar RA
    Arch Pathol Lab Med; 1992 Aug; 116(8):837-40. PubMed ID: 1497465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A patient with hemorrhage originating from an unknown coagulation pathway inhibitor].
    Komiyama Y; Munakata M; Masuda M; Kagawa H; Fukuhara S; Takahashi H
    Rinsho Byori; 2000 Dec; 48(12):1086-92. PubMed ID: 11215416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of shortened activated partial thromboplastin times: an evaluation of different commercial reagents.
    Ten Boekel E; Böck M; Vrielink GJ; Liem R; Hendriks H; de Kieviet W
    Thromb Res; 2007; 121(3):361-7. PubMed ID: 17568658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of the utility of unselected coagulation screening in general hospital practice.
    McHugh J; Holt C; O'Keeffe D
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):106-9. PubMed ID: 21245744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lupus anticoagulant. High incidence of 'negative' mixing studies in a human immunodeficiency virus-positive population.
    Clyne LP; Yen Y; Kriz NS; Breitenstein MG
    Arch Pathol Lab Med; 1993 Jun; 117(6):595-601. PubMed ID: 8503730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interference of factor VIII excess on the detection of lupus anticoagulants by the activated partial thromboplastin time].
    Guermazi S; Gorgi Y; Ayed K; Dellagi K
    Pathol Biol (Paris); 1997 Jan; 45(1):28-33. PubMed ID: 9097843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing the prothrombin time INR versus the APTT to evaluate the coagulopathy of acute trauma.
    Yuan S; Ferrell C; Chandler WL
    Thromb Res; 2007; 120(1):29-37. PubMed ID: 16887171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rare Cause of Isolated Prolonged Activated Partial Thromboplastin Time: An Overview of Prekallikrein Deficiency and the Contact System.
    Riano I; Prasongdee K
    J Investig Med High Impact Case Rep; 2021; 9():23247096211012187. PubMed ID: 33940978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital bleeding disorders in Karachi, Pakistan.
    Borhany M; Shamsi T; Naz A; Khan A; Parveen K; Ansari S; Farzana T
    Clin Appl Thromb Hemost; 2011; 17(6):E131-7. PubMed ID: 21247962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of factor VIII inhibitor in three non-hemophiliac patients].
    Kiguchi T; Niiya K; Yamawaki Y; Shima M; Harada M
    Rinsho Ketsueki; 2000 Nov; 41(11):1195-200. PubMed ID: 11193439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
    Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
    Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.